Romainville, France, October the 18th, 2006
Press Release
Cellectis is distinguished with the Ernst & Young Entrepreneur Award
as the "High Prospective Company " of Year 2006.
Romainville, France - October the 18th, 2006 - Yesterday, Cellectis has been distinguished with the Entrepeneur of the Year 2006 award (High Prospective Company). The Ernst & Young Entrepreneur Of The Year award honors entrepreneurs whose ingenuity, hard work and perseverance have created and sustained successful, growing business ventures. It recognizes the vision of Cellectis in terms of strategy and technology, and also the industrial success of the company.
André Choulika, Cellectis' Chief Executive Officer commented: "This award is a great honor for us. This 14th edition of the prize had a prestigious selection committee". He added: "This award honors the ambitious project of the company. Cellectis has been founded in 2000 as a spin-off from Institut Pasteur and is today the leader in the field of genome engineering. The award committee recognized the outstanding industrial potential of Cellectis in a rapidly growing field initiated by our company".
About Cellectis SA:
Cellectis (http://www.cellectis.com) focuses its industrial developments on new Meganucleases for in vivo DNA surgery. The company develops therapeutic applications of its systems, while its commercial offer is centered on industrial applications of new in vivo specific recombination tools.
Cellectis has 38 employees, including 14 Ph. D., and has signed more than 40 commercial contracts with major players from pharmaceutical, biotechnology and agro-industries, on its genome engineering technologies.
Copyright © Cellectis 2006. All rights reserved.
|
